MRC/BIG 2-04 | TROG 11.01 SUPREMO: A phase III randomised trial to assess the role of adjuvant chest wall irradiation in 'intermediate risk' operable breast cancer following mastectomy. SUPREMO (Selective Use of Postoperative Radiotherapy after MastectOmy) BIG 2-04 - The 10-year results (Cat B, Closed) (#21)
Boon Chua
1
- UNSW Sydney and Prince of Wales Hospital, Randwick, NSW, Australia
Content is not available at the time of publishing.